Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Clinical trial NCT01676688 · COMPLETED

Trial details

NCT number: NCT01676688
Sponsor: Laboratoire français de Fractionnement et de Biotechnologies
Status: COMPLETED
Study type: OBSERVATIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2012-01-01
Primary completion: 2012-09-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.